Fertility biomarkers to estimate metabolic risks in women with polycystic ovary syndrome

详细信息    查看全文

• 作者：Laura Detti ; Heather E. Jeffries-Boyd…
• 关键词：PCOS ; Metabolic ; Hyperandrogenism ; Hyperinsulinemia ; Glucose intolerance ; Cross ; sectional
• 刊名：Journal of Assisted Reproduction and Genetics
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：32
• 期：12
• 页码：1749-1756
• 全文大小：281 KB
• 参考文献：1.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19鈥?5.
  2.Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237鈥?5.CrossRef PubMed
  3.Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83:3078鈥?2.PubMed
  4.Nandi A, Chen Z, Patel R, Poretsky L. Polycystic ovary syndrome. Endocrinol Metab Clin North Am. 2014;43:123鈥?7.CrossRef PubMed
  5.Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38:1165鈥?4.CrossRef PubMed
  6.Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric. 2009;12 Suppl 1:22鈥?.CrossRef PubMed
  7.Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women鈥檚 health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28鈥?8.e25.CrossRef PubMed
  8.American College of Obstetricians and Gynecologists Committee on Practice Bulletins鈥擥ynecology. ACOG practice bulletin no. 108: polycystic ovary syndrome. Obstet Gynecol. 2009;114:936鈥?9.CrossRef
  9.Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038鈥?9.CrossRef PubMed
  10.Dunaif A, Fauser BC. Renaming PCOS鈥攁 two-state solution. J Clin Endocrinol Metab. 2013;98:4325鈥?.PubMedCentral CrossRef PubMed
  11.Gleicher N, Barad D, Weghofer A. Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev. 2007;7:42鈥?.CrossRef PubMed
  12.Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gartner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363鈥?.CrossRef PubMed
  13.Ott J, Aust S, Kurz C, Nouri K, Wirth S, Huber JC, et al. Elevated antithyroid peroxidase antibodies indicating Hashimoto鈥檚 thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil Steril. 2010;94:2895鈥?.CrossRef PubMed
  14.Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2007;92:S1鈥?7.CrossRef PubMed
  15.Hahan S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, et al. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome. Clin Chem Lab Med. 2007;45:202鈥?.
  16.Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Phis Ass. 1998;58:1355鈥?2. 1369鈥?0.
  17.Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab. 2010;7:7鈥?6.CrossRef
  18.Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57鈥?3.CrossRef PubMed
  19.Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists鈥?guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012;18 Suppl 1:1鈥?8.CrossRef
  20.ADA practice Guidelines: http://鈥媘cintranet.鈥媘usc.鈥媏du/鈥媋gingq3/鈥媍alculationswesb鈥媔te/鈥婣DA%20鈥婫uidelines/鈥婣DA%20鈥婤inder.鈥媝df ; accessed on January 31, 2015.
  21.Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanisms and implications for pathogenesis. Endocrin Rev. 1997;18:774鈥?00.
  22.Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen production. Endocr Rev. 1995;16:322鈥?3.CrossRef PubMed
  23.Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Ritmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab. 1991;72:83鈥?.CrossRef PubMed
  24.Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95:1073鈥?.e1-11.CrossRef PubMed
  25.Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy 2nd PF, Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88:2562鈥?.CrossRef PubMed
  26.Reh A, Grifo J, Danoff A. What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril. 2010;94:2920鈥?.CrossRef PubMed
  27.Detti L, Uhlmann RA, Fletcher NM, Diamond MP, Saed GM. Endometrial signaling pathways during ovarian stimulation for assisted reproductive technology. Fertil Steril. 2013;100:889鈥?4.CrossRef PubMed
  
• 作者单位：Laura Detti (1)
  Heather E. Jeffries-Boyd (1)
  Lucy J. Williams (1)
  Michael P. Diamond (2)
  Rebecca A. Uhlmann (1)
  
  1. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, University of Tennessee Health Science Center, Rout Center, 853 Jefferson Ave, Rm E102, Memphis, TN, 38163, USA
  2. Department of Obstetrics and Gynecology, Georgia Regents University, Augusta, GA, USA
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Gynecology
  Developmental Biology
  Human Genetics
  
• 出版者：Springer Netherlands
• ISSN：1573-7330

文摘

Purpose We sought to evaluate the relationship between the polycystic ovary syndrome (PCOS)-defining characteristics and the risk of developing metabolic complications in women presenting with complaints of infertility and/or menstrual irregularities and subsequently diagnosed with PCOS.